Message from the Director of the Department
Our department provides genome-based medicine for all-aged persons with or without any types of disease.We provide various supports for clients who need essential and preventive help for their health care and/or treatments through genomic testing and diagnosis including germline testing, prenatal testing and diagnosis for fetus, and comprehensive genome profiling testing for advanced cancer patients, etc. as well as genetic counseling for any people. We also handle with multi gene panel testing (MGPT) for those with concern of inherited tumor diseases. We, of course, work for the clients in collaboration with various internal departments or sections in our institutions as well as referring medical institutions.
Department of Clinical Genetics and
Genomic MedicineAKIRA HIRASAWA
Scope of Target diseases
We are open for those who have any inherited and non-inherited concerns with health of yourselves or any relatives.
Cancer Precision Medicine
The “Cancer Precision Medicine ” offers caner genomic testing to cancer patients, who have completed standard therapy and in feasible conditions for anticancer agents. Cancer genomic profiling is considered based on a referral from doctors at local medical institutions or Okayama University Hospital. See “Cancer Precision Medicine” for more details.
Features and Description of medical care
The “Clinical Genomics” provides genetic counseling conducted by appropriate genetic medicine specialist, such as oncologist (for familial adult-onset syndromes), obstetrician (for preconception or prenatal counseling) and so on. Supporting the patient in decision-making and coping are essential components of genetic counseling. We therefore provide accurate genetic information and offer psychological and social support before and after genetic testing so that better decisions can be made, such as by providing easy explanations and counseling for anxiety.
The “Cancer Precision Medicine” investigates somatic changes of cancer genome using cancer tissues obtained from past surgery or biopsy. Patients will be referred back to their physicians with candidates for sensitive agents for their optimal treatment that are tailored to patients’ tumors.
Genomic profiling of cancer may reveal hereditable characteristics, therefore may reveal the genetic risk not only of patients but also their families. So that, both units at the Department of Clinical Genetics and Genomic Medicine work together to provide reliable genomic medicine from cancer prevention to treatment.